Powered by Google

2005-11: A non-controlled trial of Anti-TNF-alpha Chimeric Monoclonal Antibody (Infliximab, Remicade®) in Exudative Age Related Macular Degeneration.

Medical retina
Drug research
Investigator Initiated Research
Inclusion open since 3-7-2006

This is a multi-center study in which a total of 40 patients will be treated with: Infliximab (5mg/kg) in saline solution (0.9%). The therapy will be administrated in the Internal medicine department of the Erasmus MC hospital. Patients will receive study treatment at weeks 0, 2, 6, 14, 22, 30, 38 and 46.

By visiting eyehospital.nl you are accepting the use of cookies. Read more about cookies.

Hide this message